What is LADA Diabetes?

LADA stands for Latent Autoimmune Diabetes in Adults. It’s a form of autoimmune diabetes that progresses slowly — and is misdiagnosed as Type 2 diabetes far more often than most doctors realize.

What Is LADA Diabetes?

LADA stands for Latent Autoimmune Diabetes in Adults. It is sometimes called Type 1.5 Diabetes, though that label can be misleading — because LADA is not a midpoint between Type 1 and Type 2. Its root cause is autoimmune, exactly like Type 1. Most experts consider LADA a subtype of Type 1 diabetes, distinguished primarily by its slower, more gradual progression.

In LADA — as in Type 1 — the immune system mistakenly attacks and destroys the beta cells in the pancreas. Beta cells are the only cells in the human body that produce insulin. Without them, the body cannot regulate blood glucose, and insulin becomes necessary for survival.

The word “Latent” in LADA refers to the gradual, hidden nature of this onset. Unlike classic Type 1, which often appears suddenly and dramatically (sometimes with a hospitalization for a condition called Diabetic Ketoacidosis, or DKA), LADA develops over months or years. In the early stages, the pancreas is still producing some insulin — enough that a person may not immediately need insulin injections. This is part of why it’s so often confused with Type 2.

How Common Is LADA?

LADA is far more common than most people — and many healthcare providers — realize. According to the International Diabetes Federation, there were approximately 588 million people living with diabetes worldwide in 2024. If even 10% of those have LADA, that’s roughly 58.8 million people. The IDF projects a 45% increase in diabetes prevalence by 2050.

Yet LADA remains poorly understood and chronically underdiagnosed, in part because the diagnostic tests that would identify it are often never ordered.

LADA vs. Type 1 vs. Type 2 Diabetes

Understanding how LADA differs from the other main types of diabetes is the key to understanding why misdiagnosis is such a persistent problem — and why it matters so much.

Feature	Type 1	LADA (Type 1.5)	Type 2
Root cause	Autoimmune	Autoimmune	Insulin resistance
Age of onset	Any age	Usually adult (30+)	Usually adult
Speed of onset	Sudden	Gradual (months to years)	Gradual
Autoantibodies present?	Yes	Yes	No
Insulin needed?	Immediately, always	Eventually — often not at first	Sometimes, in later stages
C-peptide levels	Very low	Low to declining	Normal to high
Responds to Type 2 meds?	No	Initially, but not long-term	Yes
Body weight at onset	Often normal/low	Often normal or lower	Often higher

The critical takeaway: LADA looks like Type 2 on the surface (adult onset, may initially respond to diet or medication), but its underlying biology is identical to Type 1. This distinction is not academic — it determines whether someone receives the right treatment.

Symptoms of LADA Diabetes

LADA shares many of the classic symptoms of diabetes. Because the onset is gradual, symptoms may develop slowly or be easy to rationalize as other things — fatigue blamed on stress, thirst blamed on a hot day, weight loss celebrated rather than questioned.

Common symptoms include:

🚽 Frequent urination, often at night

💧 Extreme, persistent thirst

⚖️ Unexplained weight loss

😴 Unusual fatigue

👁️ Blurry vision

🍽️ Increased hunger

🖐️ Numbness or tingling in hands or feet

🦠 Slow-healing wounds or frequent infections

🏃 Muscle aches

🧠 Brain fog or difficulty concentrating

Early Warning Signs Before Diagnosis

In the book Success with LADA Diabetes, Linnea describes what she calls the “Flaky Pancreas Stage” — a period before formal diagnosis when the pancreas is already struggling, but standard blood tests still show normal results. Signs during this phase can include:

• Feeling unwell after eating foods high in sugar or fast-acting carbohydrates
• Shakiness or dizziness after exercise (blood sugar dropping quickly)
• Reactive hypoglycemia — blood sugar dropping too low a few hours after eating
• Recurrent yeast infections (elevated glucose creates a favorable environment for yeast)
• Mood swings, irritability, or anxiety linked to blood sugar fluctuations

We now know that the autoantibodies associated with LADA and Type 1 diabetes can be present for years before blood glucose rises to diagnosable levels. This is why some researchers recommend early screening, especially for people with a family history of autoimmune conditions.

Why LADA Is So Often Misdiagnosed

LADA is misdiagnosed as Type 2 diabetes in a significant number of cases — estimates range from 5% to 20% of all adults diagnosed with Type 2. The misdiagnosis happens for understandable reasons, but the consequences can be serious.

Why misdiagnosis happens:

• LADA typically presents in adulthood — the same age range as Type 2.
• In the early stages, diet changes and Type 2 medications (like Metformin) may initially improve blood glucose, masking the underlying autoimmune process.
• Type 2 is far more common, so it is assumed by default without additional testing.
• The diagnostic tests that would reveal LADA — an autoantibody panel and a C-peptide test — are frequently not ordered.
• Unexplained weight loss or a normal body weight may not raise a red flag in the same way it should.

The misdiagnosis of LADA as Type 2 isn’t just a paperwork problem. Treatments designed for Type 2 diabetes address insulin resistance — but that’s not what’s happening in LADA. In LADA, the problem is insulin deficiency: the pancreas is being destroyed and simply cannot produce enough insulin. Some medications used for Type 2 (such as sulfonylureas) may even place additional strain on a pancreas that is already struggling.

How to Get a Correct Diagnosis

The good news: the tests that can identify LADA exist and are well-established. The challenge is simply ensuring they are ordered.

Tests That Do NOT Distinguish LADA from Type 2

The most common diabetes tests tell you that blood glucose is high — but not why. These include the A1C test, the Fasting Blood Glucose test, and the Oral Glucose Tolerance Test. All three are insufficient on their own to differentiate LADA from Type 2.

Tests That CAN Identify LADA

Diabetes Autoantibody Panel

This panel tests for proteins produced by the immune system that signal an autoimmune attack on the pancreas. The most important marker for LADA is GAD-65 (Glutamic Acid Decarboxylase), which is elevated in the majority of LADA cases. The full panel typically includes Islet Cell Antibodies (ICA), Insulinoma-associated-2 autoantibodies (IA-2A), and Insulin Autoantibodies (IAA). The presence of any of these autoantibodies distinguishes LADA from Type 2.

C-Peptide Test

C-peptide is a protein produced during insulin manufacture. Because it stays in the blood longer than insulin itself, measuring it is a reliable way to assess how much insulin your pancreas is producing. In LADA, C-peptide levels are typically low — because the pancreas is producing less and less insulin. In Type 2, C-peptide levels are often elevated, because the pancreas is compensating for insulin resistance by producing more. This difference is clinically significant.

The LADA Journey: What to Expect

LADA is a progressive condition. Understanding the stages of its progression can help you stay ahead of it — practically and emotionally.

The Flaky Pancreas Stage (Pre-diagnosis)

The autoimmune process may already be underway while blood glucose tests still look normal. Subtle symptoms — shakiness, sensitivity to certain foods, recurrent infections — may hint at something, but A1C may not be elevated yet. This stage can last years.

Diagnosis (often as “Type 2”)

Classic diabetes symptoms appear: extreme thirst, frequent urination, sometimes dramatic weight loss. A blood glucose test confirms diabetes, but without additional testing, LADA is often misdiagnosed as Type 2. Diet changes and medications may initially help.

The Honeymoon Period

In the early stages of LADA, the pancreas is still producing some insulin. This period — sometimes called the honeymoon — can last months or years. Diet, exercise, and possibly oral medications may keep blood glucose in a reasonable range. The key is recognizing that this window will close, and planning accordingly. Starting small doses of insulin early may actually help extend this period by preserving remaining beta cell function.

Increasing Insulin Need

As the autoimmune destruction of beta cells continues, the pancreas produces less and less insulin. What worked before stops working. This is not a failure of willpower or diet — it is the natural progression of an autoimmune condition. Insulin becomes necessary.

Full Insulin Dependence

Eventually, LADA becomes clinically indistinguishable from Type 1 diabetes. The pancreas is no longer producing meaningful amounts of insulin, and external insulin — through injections or an insulin pump — is essential. At this stage, it is appropriate to think of yourself as a Type 1 diabetic and seek the same care.

Treatment: Why Insulin Matters

Insulin is not a last resort for LADA. It is the correct treatment — and ultimately the only treatment that addresses the underlying problem.

In the early stages, dietary changes (reducing carbohydrates) and increasing exercise can significantly improve blood glucose by increasing insulin sensitivity and reducing insulin demand. These approaches may extend the honeymoon period and improve blood sugar initially.

But as the autoimmune process progresses, the pancreas produces less insulin regardless of lifestyle. At that point:

• Oral medications for Type 2 (which work by stimulating more insulin production or reducing insulin resistance) become increasingly ineffective.
• Some medications, particularly sulfonylureas, may place additional stress on a pancreas that is already failing.
• External insulin — through pens, syringes, or an insulin pump — becomes the correct and necessary treatment.

Dosing insulin is challenging. It requires learning, adjustment, and working closely with an endocrinologist or certified diabetes care specialist. Modern diabetes technology — continuous glucose monitors (CGMs) and automated insulin pumps — has made this dramatically more manageable than it was even a decade ago.

Why Treating Diabetes Is Worth It

In the early stages of LADA, when symptoms may be mild, it can be tempting to defer aggressive treatment. This is a significant risk. Like high blood pressure, high blood glucose can cause serious, progressive damage that is largely invisible until it is advanced.

Untreated or under-treated diabetes can cause:

• Vision loss — damage to the small blood vessels in the retina (diabetic retinopathy)
• Kidney disease — leading to kidney failure and dialysis
• Nerve damage — tingling, numbness, burning pain, and in severe cases, foot amputations
• Cardiovascular disease — heart attack and stroke

The landmark Diabetes Control and Complications Trial (DCCT), which ran from 1983 to 1993, demonstrated definitively that intensive blood glucose management in Type 1 diabetes reduced the risk of retinopathy by 50–54%, kidney disease by 34–43%, and nerve damage by 69%. These numbers apply directly to LADA, which shares the same underlying biology.

With proper diagnosis and treatment, these complications are largely preventable. The hard work of managing blood glucose today is an investment in the decades ahead.

---

Medical Disclaimer: This page is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. The author is not a physician or licensed healthcare provider. Do not make changes to your medications, insulin, diet, or treatment plan without consulting a qualified healthcare professional. If you are experiencing a medical emergency, seek immediate medical attention.